Quantcast

Latest Hospira Inc. Stories

2014-07-14 23:08:16

On July 11, the FDA informed that one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, by Hospira Inc., is recalled due to mold contamination. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 14, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Hospira Lactated...

2014-07-07 08:27:44

Editor Note: For more information about this release, please scroll to bottom. LONDON, July 7, 2014 /PRNewswire/ -- The US markets on Thursday, July 3, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 17,068.26, up 0.54% and the NASDAQ Composite closed at 4,485.93, up 0.63%. The S&P 500 finished the session 0.55% higher at 1,985.44. During the trading session, nine out of ten sectors finished on a higher note. The S&P 500 Health Care Sector...

2014-07-04 16:21:01

-- Purchase enhances cost-competitiveness, paves way for future development -- LAKE FOREST, Ill., July 4, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd. (BSE: 524372, NSE:...

2014-07-01 12:28:22

LAKE FOREST, Ill., July 1, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its second-quarter 2014 results on Wednesday, July 30, 2014 at 8 a.m. Central time. The company will release its second-quarter results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call and related material will be available...

2014-06-23 12:28:46

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Testicular Cancer Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_testicular_cancer_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Testicular Cancer Drugs market to grow at a CAGR of 4.02 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of testicular...

2014-05-27 12:31:59

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Pain Management Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_pain_management_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Pain Management Drugs market will grow at a CAGR of 3.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The...

2014-05-07 12:31:01

LAKE FOREST, Ill., May 7, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today held its 2014 Annual Meeting of Shareholders in San Francisco. The agenda included votes on four items. During the annual meeting, shareholders: -- elected the following directors, whose terms expire in 2015: Irving W. Bailey, II; F. Michael Ball; Connie R. Curran, RN, Ed.D; William G. Dempsey; Dennis M. Fenton;...

2014-04-30 08:32:23

-- Maintains net sales and adjusted* earnings-per-share projections for full-year 2014 -- LAKE FOREST, Ill., April 30, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the first quarter ended March 31, 2014. Net sales for the quarter were $1.1 billion and adjusted* diluted earnings per share were $0.60. (Adjusted* measures exclude certain specified items as described later in this...

2014-03-31 16:26:44

LAKE FOREST, Ill., March 31, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its first-quarter 2014 results on Wednesday, April 30, 2014 at 8 a.m. Central time. The company will release its first-quarter results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call and related material will be available...

2014-03-27 12:30:10

LAKE FOREST, Ill., March 27, 2014 /PRNewswire/ -- Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that, for the second consecutive year, its TheraDoc(TM) Infection Control Assistant(TM) software has been ranked as the top product in the Infection Control & Monitoring software category in the recently released Best in KLAS Awards 2013: Software and Services Report (more information available at www.theradoc.com). The...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related